The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Sat., Sep. 19, 7:34 AM

Slide #52. Mylan N.V. Aspen Pharmacare Holdings Limited's thrombosis business in Europe

Acquirer: Mylan N.V. (NASDAQ:MYL)
Acquiree: Aspen Pharmacare Holdings Limited's thrombosis business in Europe
Details: Mylan N.V. (NASDAQ: MYL) today announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for EUR 641.9 million, subject to customary closing conditions and European regulatory clearances. The transaction is expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRISTM upon the completion of Mylan's previously announced combination with Upjohn that is expected to close in the fourth quarter of 2020.

Mylan is engaged in the global development, licensing, manufacture, marketing and distribution of generic, branded generic, brand-name and over-the-counter (OTC) pharmaceutical products for resale by others and active pharmaceutical ingredients (API) through three reportable segments on a geographic basis, North America, Europe and Rest of World. Co.'s API business is conducted through its subsidiary, Mylan Laboratories Limited, which is included within its Rest of World segment. Among Co.'s branded prescription products are EpiPen® Auto-Injector, Perforomist® Inhalation Solution and Dymista®. Co.'s OTC portfolio includes Cold-EEZE®, MidNite® and Vivarin®, as well as other products.

Mylan SEC Filing Email Alerts Service

Open the MYL Page at The Online Investor »

Company Name: 
Mylan NV
Stock buyback: 
MYL buyback
Drugs & Pharmaceuticals
Number of ETFs Holding MYL: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the MYL Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Buy (2.73 out of 4)
24th percentile
(ranked lower than approx. 76% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.